Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | TP53 | P04637 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | CNR2 | P34972 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amylmetacresol SCHEMBL29897625 | 1.00 | TYR (0.68) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL3358965 | 0.98 | TYR (0.71) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL8402868 | 0.98 | TYR (0.71) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL8590686 | 0.98 | TYR (0.71) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL9504248 | 0.98 | TYR (0.71) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL901087 | 0.94 | TYR (0.69) | TYRCYP3A4MAPTTP53MEN1 | |
| Butane SCHEMBL28342368 | 0.92 | TYR (0.67) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL8400481 | 0.90 | TYR (0.58) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL28329857 | 0.89 | TYR (0.62) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL28858657 | 0.88 | TYR (0.53) | TYRCYP3A4MAPTTP53MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3793520-B1 | AN ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE THROAT COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | FERTIN PHARMA AS (DK) | 2025-04-30 | — | — | EP | claimed |
| EP-3793518-B1 | AN ORAL TABLET FOR TASTE MASKING OF ACTIVE INGREDIENTS COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | FERTIN PHARMA AS (DK) | 2025-03-26 | — | — | EP | claimed |
| WO-2025034143-A1 | PHARMACEUTICAL COMPOSITION OF GRAMICIDIN S FOR TREATING INFECTIOUS INFLAMMATORY DISEASES OF THE ORAL CAVITY AND THROAT | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ВАЛЕНТА-ИНТЕЛЛЕКТ" | 2025-02-13 | — | — | WO | claimed |
| US-20250009663-A1 | Mouthwash For Oral Care Benefits | FERTIN PHARMA A/S (DK) | 2025-01-09 | — | — | US | claimed |
| EP-4088716-B1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | FERTIN PHARMA AS (DK) | 2024-10-16 | — | — | EP | claimed |
| US-12109312-B2 | Oral tablet for taste masking of active ingredients | FERTIN PHARMA A/S (DK) | 2024-10-08 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| EP-3093010-B1 | ORAL COMPOSITION COMPRISING A COOLING AGENT | RECKITT BENCKISER HEALTHCARE (GB) | 2024-06-19 | — | — | EP | claimed |
| EP-3407890-B1 | PHARMACEUTICAL PREPARATION AND THE USE THEREOF FOR TREATING VIRAL LARYNGITIS | SOMMER PETER (DE) | 2023-07-19 | — | — | EP | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| EP-0290676-B1 | Improved disinfectant polymeric coatings for hard surfaces | ECOLAB INC (US) | 1994-08-17 | — | — | EP | claimed |
| EP-0580627-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRITIS | SMITHKLINE BEECHAM PLC (GB) | 1994-02-02 | — | — | EP | claimed |
| EP-0290739-B1 | IMPROVED DISINFECTANT POLYMERIC COATINGS FOR HARD SURFACES | ECOLAB INC. (US) | 1993-02-10 | — | — | EP | claimed |
| WO-1992018111-A2 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRITIS | SMITHKLINE BEECHAM PLC (GB) | 1992-10-29 | — | — | WO | claimed |
| US-5061485-A | Film forming acrylic polymer | ECOLAB INC. (US) | 1991-10-29 | — | — | US | claimed |
| US-4999386-A | Germicidal agent contained in polymer film, sustained release | ECOLAB INC. (US) | 1991-03-12 | — | — | US | claimed |
| CN-1007869-B | Process for the preparation of carbonated liquids suitable for human consumption, in particular carbonated soft drinks | GYORGY TIMAR (HU) | 1990-05-09 | — | — | CN | claimed |
| CN-85101286-A | Process for the preparation of carbonated liquids suitable for human consumption, in particular carbonated soft drinks | — | 1987-01-17 | — | — | CN | claimed |
| US-4468508-A | Glycidyl ether of novolak type substituted phenolic resin, process for producing the same, and encapsulating compound composed mainly of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | TYR 2156/4885CYP3A4 3571/4885MAPT 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.